Articles published by Actinogen Medical
Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November
October 28, 2026
From Actinogen Medical
Via GlobeNewswire
Tickers
ASX:ACW
Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
April 01, 2026
From Actinogen Medical
Via GlobeNewswire
Tickers
ASX:ACW
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
April 30, 2025
From Actinogen Medical
Via GlobeNewswire
Tickers
ASX:ACW